Gannett Co.’s stock fell by 13% following the release of its full-year financial results. The company met revenue targets with $2.5 billion and reported losses of $0.18 per share, which were better than expected. Analysts predict a 3.5% revenue decline for Gannett

Merck & Co., Inc. (NYSE:MRK), a leader in healthcare innovation, is attracting insider interest amid a volatile stock market. Despite a recent stock price decline of 31.31% over the past year, two insiders invested approximately $1.58 million at an average price of

Boeing faces mixed outlooks, with potential Air Force One delays until 2029 causing concern. Boeing Defense, Space & Security continues to struggle with fixed-price challenges and cost overruns. Emirates’ cautious stance on Boeing 777X deliveries hints at possible delays until 2027. Possible

RLI Corp. insiders recently purchased shares at an average price of $72.14, signaling confidence in the company’s potential. Despite a 9.16% stock decrease this year, RLI’s strategic insider activities suggest future growth prospects. RLI boasts a solid performance with stock rising 5.21%